Lv3
298 积分 2023-01-12 加入
Efficacy and safety of SHR-1701 combined with chemoradiotherapy as neoadjuvant treatment for locally advanced rectal cancer
1个月前
已完结
Safety and effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition: an updated review
2个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
2个月前
已完结
Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy
2个月前
已完结
Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
3个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
3个月前
已完结
Epidemiology of IgA Nephropathy: A Global Perspective
3个月前
已完结
KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)
3个月前
已完结
Effect of Pravastatin in People with Diabetes and Chronic Kidney Disease
3个月前
已关闭
皖公网安备34019202002308
